ОбзорГрафикНовостиTraderScreen

Morgan Stanley Discount Zert BNTX.../  DE000ME5DBQ6  /

Stuttgart
12.11.2024  19:34:33 Изменение+0.31 Бид19:48:34 Предложение19:48:34 Базовый актив Цена исполнения Дата истечения Тип опциона
74.12EUR +0.42% 74.13
Величина цены спроса: 1,500		 75.41
Величина цены предложения: 1,500		 BioNTech SE - USD 31.12.2024 Call
TeleTrader 04.11 BioNTech's revenue at €1.2 billion in Q3
TeleTrader 04.11 Earnings preview: Palantir, Aramco and more in action-packed week
GlobeNewswire 29.08 Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth
GlobeNewswire 29.08 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
TeleTrader 22.08 FDA okays Moderna, Pfizer updated vaccines
GlobeNewswire 22.08 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 16.08 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 14.08 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 08.08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08.08 Genmab Updates 2024 Financial Guidance
TeleTrader 05.08 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 05.08 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05.08 Genmab Takes Full Control of Acasunlimab Development Program
GlobeNewswire 01.08 Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 30.07 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 22.07 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 27.06 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 24.06 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 01.06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29.05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 28.05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21.05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 21.05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 17.05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 17.05 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates